by Megan Mouw
Most of us want to lower our cardiometabolic risk in order to live long and healthy lives; that is, we want to have what doctors define as a low risk of developing cardiovascular disease and diabetes.
by GMFH Editing Team
Gut health has emerged as a potential target in people suffering from metabolic syndrome. A new randomized controlled trial has found that yogurt may help ameliorate insulin resistance in obese women with nonalcoholic fatty liver disease and metabolic syndrome by involving the gut microbiota.
by GMFH Editing Team
Research over the last decade has shown the contribution of our gut microbiome in conditions apparently unrelated to the gut. Now scientists suggest that the gut microbiota may have a causal role in mediating disrupted insulin sensitivity and ovarian function in polycystic ovary syndrome.
by Andreu Prados
Metabolic syndrome, a group of several disturbances including obesity, insulin resistance, and non-alcoholic fatty liver disease that pose as risk factors for diabetes and heart disease, has been previously associated with vitamin D insufficiency/deficiency in epidemiological studies. In addition, gut